It doesn't have enough ratings yet to judge what users think.
V.I.B.E.S is made and published by Dante Brooks. AppBrain is an independent app data site and isn't affiliated with Dante Brooks. The app name, icon, screenshots and description belong to Dante Brooks and are shown as published on the App Store.
About V.I.B.E.S
V.I.B.E.S is a social networking app developed by Dante Brooks.
User Ratings
V.I.B.E.S is rated 5.00 out of 5 stars. The rating is based on 3 ratings.
App Information
V.I.B.E.S is freely available from the App Store. The app size is 155.93 MB. The latest version available is 2.1.8. The last update was on November 4, 2025.
Technical Requirements
The app has a content rating of Medium Maturity. The app has been available on the App Store since September 2025.
More data about V.I.B.E.S
| Price | Free |
| Rating | 5.00 based on 3 ratings |
| Ranking | Not ranked |
| Version | 2.1.8 |
| App size | 155.9 MB |
| Maturity | Medium Maturity |
Screenshots
Alternatives to V.I.B.E.S
Changelog of V.I.B.E.S
No changelog data
Developer information for Dante Brooks
Address:
Comments on V.I.B.E.S for iOS
We don't have enough comments to show example comments. Please check back later.
App Store Rankings for V.I.B.E.S
Technologies used by V.I.B.E.S
Frequently asked questions about V.I.B.E.S
Is V.I.B.E.S free?
Yes. V.I.B.E.S is free on the App Store.
Is V.I.B.E.S still available?
Yes. V.I.B.E.S is on the App Store, and the last update we saw was on November 4, 2025.
How large is V.I.B.E.S?
V.I.B.E.S is 155.93 MB.
Is V.I.B.E.S suitable for children?
App Store gives V.I.B.E.S a medium maturity rating, so it is not meant for young children.
How do people rate V.I.B.E.S?
V.I.B.E.S scores 5.00 out of 5 stars, from 3 ratings on the App Store.
Who made V.I.B.E.S?
V.I.B.E.S was developed by Dante Brooks. It is listed in the social networking category on the App Store.
What are the best alternatives to V.I.B.E.S?
People looking at V.I.B.E.S also look at these social networking apps: TimbrTV, Catalink, Quotient Advisor Community, iCORKu, Crofam.